1. Home
  2. TRIPS

TRIPS

World Trade Organization Members Embark on Review of the TRIPS Agreement
Pressure from European countries related to the use of TRIPS Flexibilities
WTO: Pharma-producing nations remain evasive on TRIPS Agreement review
The WTO Failed the World in Covid Pandemic-related technology and intellectual property cannot remain in its authority.
The WTO Failed the World in Covid Pandemic-related technology and intellectual property cannot remain in its authority.
World trade cooperation will be put to the test in Abu Dhabi
What’s at Stake at the WTO’s 13th Ministerial Conference This Month in Abu Dhabi?
How Should the WHO Pandemic Treaty Negotiations Tackle Intellectual Property?
WTO Members Agree to Disagree on TRIPS Extension Decision; Misfired: When the WTO Got Lovesick
WTO fails to reach agreement on providing global access to Covid treatments
TRIPS Council finalizes preparations for MC13
WTO MC13: TRIPS Issues and Technology Transfer
WTO MC13: TRIPS Issues and Technology Transfer
Evergreening of Medicine Patents is ‘Abuse’ of Intellectual Property System
Reigniting the Spirit of the Doha Declaration: Why a TRIPS Waiver Extension is Key to the Legitimacy of the World Trade Organization
Corporate Greed and Rich Countries’ Cowardice Lead WTO to Abandon Proposed Sharing of COVID Treatment Technologies
WTO to Pull the Plug on Extension Decision on COVID-19 Tests & Treatments. TRIPS Chair Calls for “Conclusion” as Talks "Exhausted"
TRIPS Waiver Decision for Equitable Access to Medical Countermeasures in the Pandemic: COVID-19 Diagnostics and Therapeutics
TRIPS Waiver Decision for Equitable Access to Medical Countermeasures in the Pandemic: COVID-19 Diagnostics and Therapeutics
Members push mandated issues to trade ministers at MC13
Senior officials say their views on agriculture & DS reform “doctored”
USITC report confirms inadequacy of VLs, tier-pricing, access schemes
GC chair’s report suggests bleak outcomes for TRIPS & PSH
Subscribe to TRIPS